Newstrike is a Canadian Cannabis company committed to growth.
1) Growth. to help patients get the medicine they need produced to the quality standards they deserve.
2) Growth of best-in-class supply, by applying our proprietary approach to increase capacity to identify, design, build and manage additional facilities to meet the evolving requirements of the Canadian market;
Publicly traded on the TSX-V under the symbol NR and federally licenced by Health Canada for cultivation through its proposed wholly owned subsidy Hemisphere Pharmaceuticals: Newstrike is committed to reliability, delivering long term value to our investors and growing responsibly.
For more information please sign up for updates